Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis

Journal of the Neurological Sciences

Volumn 239, Issue 1, 2005, Pages 95-99

  Tortorella, Carla ^a   Bellacosa, Alessandra ^b   Paolicelli, Damiano ^b   Fuiani, Aurora ^b   Di Monte, Elisabetta ^b   Simone, Isabella Laura ^b   Giaquinto, Patrizia ^b   Livrea, Paolo ^b   Trojano, Maria ^b  

^a Ospedale San Paolo   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Age; Gd enhancement; Multiple sclerosis

Indexed keywords

GADOLINIUM;

ADULT; AGING; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; SCORING SYSTEM;

ADULT; AGE FACTORS; AGING; BRAIN; ENCEPHALITIS; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 27744503132     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2005.08.006     Document Type: Article

References (33)

1. C.P. Hawkins, P.M.G. Munro, F. Mackenzie, J. Kesselring, P.S. Tofts, and E.P. du Boulay Duration and selectivity of blood brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers Brain 113 1990 365 378
2. S.P. Morrissey, H. Stodal, U. Zettel, C. Simonis, S. Jung, and R. Kiefer In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis. Quantification of inflammation and oedema Brain 119 1996 239 248
3. R.I. Grossman, F. Gonzalez-Scarano, S.W. Atlas, S. Galetta, and D.H. Silberberg Multiple sclerosis: gadolinium enhancement in MR imaging Radiology 161 1986 721 725
4. D. Katz, J.K. Taubenberger, B. Cannella, D.E. McFarlin, C.S. Raine, and H.F. McFarland Correlation between magnetic resonance imaging findings and lesion development in chronic active multiple sclerosis Ann Neurol 34 1993 661 669
5. G.M. Nesbit, G.S. Frobes, B.W. Scheithauer, H. Okazaki, and M. Rodriguez Multiple sclerosis: histopathological and MR and/or CT correlation in 37 cases at biopsy and 3 cases at autopsy Radiology 180 1991 467 474
6. D.H. Miller, P. Rudge, J. Johnson, B.E. Kendall, D.G. MacManus, and I.F. Moseley Serial gadolinium-enhanced magnetic resonance imaging in multiple sclerosis Brain 111 1988 927 939
7. C. Tortorella, M. Codella, M.A. Rocca, C. Gasperini, R. Capra, and S. Bastianello Disease activity in multiple sclerosis studied by weekly triple-dose magnetic resonance imaging J Neurol 246 1999 689 692
8. D.H. Miller, P.S. Albert, F. Barkhof, G. Francis, J.A. Frank, and S. Hodgkinson Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis Ann Neurol 39 1996 6 16
9. M. Filippi, and D.H. Miller MRI in the differential diagnosis and monitoring the treatment of multiple sclerosis Curr Opin Neurol 9 1996 176 186
10. F. Fazekas, F. Barkhof, M. Filippi, R.I. Grossman, D.K. Li, and W.I. McDonald The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis Neurology 53 1999 448 456
11. W.I. McDonald, A. Compston, G. Edan, D. Goodkin, H.P. Hartung, and F.D. Lublin Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis Ann Neurol 50 2001 121 127
12. F. Barkhof, M. Filippi, D.H. Miller, P. Scheltens, A. Campi, and C.H. Polman Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis Brain 120 1997 2059 2069
13. P.D. Molyneux, M. Filippi, F. Barkhof, C. Gasperini, T.A. Yousry, and L. Truyen Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis Ann Neurol 43 1998 332 339
14. L. Kappos, D. Moeri, E.W. Radue, A. Schoetzau, K. Schweikert, and F. Barkhof Predictive value of gadolinium-enhanced MRI for relapse rate and changes in disability/impairment in multiple sclerosis: a metanalysis Lancet 353 1999 964 969
15. M.P. Sormani, P.D. Molyneux, C. Gasperini, F. Barkhof, T.A. Yousry, and D.H. Miller Statistical power of MRI monitored trials in multiple sclerosis: new data and comparison with previous results J Neurol Neurosurg Psychiatry 66 1999 465 469
16. N. Tubridy, H.J. Ader, F. Barkhof, A.J. Thompson, and D.H. Miller Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing remitting and secondary progressive subgroups using placebo controlled parallel groups J Neurol Neurosurg Psychiatry 64 1998 50 55
17. M.E. Smith, N.L. Eller, H.F. McFarland, M.K. Racke, and C.S. Raine Age dependence of clinical and pathological manifestation of autoimmune demyelination. Implications for multiple sclerosis Am J Pathol 155 1999 1147 1161
18. M. Trojano, M. Liguori, G.B. Zimatore, R. Bugarini, C. Avolio, and D. Paolicelli Age related disability in multiple sclerosis Ann Neurol 51 2002 475 480
19. L.A. Stone, E. Smith, P.S. Albert, C.N. Bash, H. Maloni, and J.A. Frank Blood-brain barrier disruption on contrast enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender and age Neurology 45 1995 1122 1126
20. M. Filippi, J.S. Wolinsky, M.P. Sormani, G. Comi the European/Canadian Glatiramer Acetate Study Group Enhancement frequency decreases with increasing age in relapsing-remitting multiple sclerosis Neurology 56 2001 422 423
21. J.S. Wolinsky, P.A. Narayana, J.H. Noseworthy, F.D. Lublin, J.N. Whitaker, and A. Linde Linomide in relapsing and secondary progressive MS. Part II. MRI results Neurology 54 2000 1734 1741
22. S. Mechati, and H. Peyro-St-Paul iMed: a new electronic database for monitoring patients with multiple sclerosis Mult Scler 7 Suppl. 1 2001 S31
23. J.F. Kurtzke Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1983 1444 1452
24. F. Barkhof, M. Filippi, J.H. van Waesberghe, P. Molyneux, M. Rovaris, and G. Lycklama a Nijeholt Improving interobservers variation in reporting gadolinium enhanced MRI lesions in MS Neurology 49 1997 1682 1688
25. F.D. Lublin for the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis Defining the clinical course of multiple sclerosis: results of an international survey Neurology 46 1996 907 911
26. S.J. Bolton, and V.H. Perry Differential blood-brain barrier breakdown and leucocyte recruitment following excitotoxic lesions in juvenile and adults rats Exp Neurol 154 1998 231 240
27. P. Duquette, T.J. Murray, J. Pleines, G.C. Ebers, D. Sadovnick, and P. Weldon Multiple sclerosis in childhood: clinical profile in 125 patients J Pediatr 111 1987 359 363
28. I.L. Simone, D. Carrara, C. Tortorella, M. Liguori, V. Lepore, and F. Pellegrini Course and prognosis in early onset multiple sclerosis. Comparison with adult-onset forms Neurology 59 2002 1922 1928
29. A. Ghezzi, C. Pozzilli, M. Liguori, M.G. Marrosu, N. Milani, and C. Milanese Prospective study of multiple sclerosis with early onset Mult Scler 8 2002 15 18
30. D.K.B. Li, M. Filippi, U. Petkau, U. Held, M. Daumer for The MRI Working Group of the Sylvia Lawry Centre for MS Research T2 lesion burden on MRI plateaus as disability accumulates Mult Scler 9 S1 2003 S58
31. D.M. Mezzapesa, M. Rocca, A. Falini, M.E. Rodegher, A. Ghezzi, and G. Comi A preliminary diffusion tensor and magnetization transfer magnetic resonance imaging study of early onset multiple sclerosis Arch Neurol 61 2004 366 368
32. A.J. Thompson, D.H. Miller, B.D. Youl, D. MacManus, S. Moore, and D. Kingsley Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration Neurology 42 1992 60 63
33. M. Filippi, P. Rossi, A. Campi, B. Colombo, C. Pereira, and G. Comi Serial contrast-enhanced MR in patients with multiple sclerosis and varying levels of disability AJNR Am J Neuroradiol 18 1997 1549 1556